Home Press Releases Europe Drives Global Organ Preservation Solutions Market to Reach US$0.20 Bn by 2019
Europe Drives Global Organ Preservation Solutions Market to Reach US$0.20 Bn by 2019
Technological advancements and expanding geriatric population are some of the major factors driving the global organ preservation solutions market, states Transparency Market Research in its latest report. The report, titled “Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, indicates that registering a 16.5% CAGR from 2013 to 2019, the value of the organ preservation solutions market is set to rise from US$0.06 billion in 2012 to US$0.20 billion by 2019.
Browse Full Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Report With Full TOC @ http://www.transparencymarketresearch.com/organ-preservation-solutions.html
The organ preservation solutions market sees immense potential in partnering with medical institutes and research organizations in order to widen and retain the customer base. The main challenges that this market faces are widening gap between organ donors and patients receiving transplant organs, and high cost of the transplant procedure.
By solution, the market for organ preservation solutions is fragmented into Viaspan, Human bioSystem (HBS) Solution, Perfadex, Lifor, Renograf, siRNA Transplant Solutions, Hypothermosol, and Custodiol HTK (Histidine-Tryptophan-Ketoglutarate). In terms of revenue, Viaspan and Custodial together held a share of over 75% in 2012. However, Custodial is anticipated to be the most rapidly developing segment by 2019, growing at a 17.1% CAGR from 2013 to 2019.On the basis of technique, the market for organ preservation solutions is segmented into static cold storage (SCS), hypothermic perfusion preservation (HPP), and others. SCS is the most widely used organ preservation solution, being cheaper and more user-friendly compared to HPP. However, lack of organ donors to fulfill a surging demand for organs is likely to boost the market for HPP over the forecast period. This segment is estimated to register a strong CAGR of 19.2% from 2013 to 2019.
Geographically, the global organ preservation solutions market is divided into North America, Europe, Asia Pacific, and Rest of the World. Europe dominated the worldwide market in 2012 in terms of revenue and this region is predicted to register a 17.3% CAGR from 2013 to 2019, also making it the fastest growing regional market for organ preservation solutions. The impressive presence of organ donors in Europe and growth of geriatric population are responsible for its strong growth. According to the European Commission, in 2011, the number of deceased organ donors in the U.K. alone stood at 1,056. In the entire European region, the number of deceased organ donors has risen from 9,152 in 2009 to 9,604 in 2011.
Some of the prominent players operating in the global organ preservation solutions market are Claris Lifesciences Limited, XVIVO Perfusion AB, 21st Century Medicine, Teva Pharmaceutical Industries Ltd., BioLife Solutions, Inc., Lifeline Scientific, Dr. Franz Köhler Chemie GmbH, ToleroTech, Inc., BioTime, Inc., CryoLife, Inc., and Bristol-Myers Squibb.
Organ Preservation Solutions Market, by Solution
- Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
- Human bioSystem (HBS) Solution
- siRNA Transplant Solutions
Organ Preservation Solutions Market, by Preservation Technique
- Hypothermic Perfusion Preservation (HPP)
- Static Cold Storage (SCS)
Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/global-organ-preservation-solutions.htm
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Mr. Sudip. S
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
- Cardiovascular Imaging and Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 - 2023
Cardiovascular diseases (CVD) are the most common causes of patient hospitalization and mortality in many developed nations. It continues to be the leading cause of death worldwide as well. It is imperative for a physician to perform cardiovascular imaging test to diagnose heart condition and during subsequent management of any cardiac disorder. Cardiovascular imaging (CV imaging) enables radiologist to see inside the body and shows the structure of heart in great detail. The physician can un...
- Cell Expansion Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023
Cell expansion is defined as the production of daughter cells which arise originally from the single cell. Cell expansion is beneficial either therapeutically as drug screening tools or for core research purposes. Currently, cell expansion is majorly used for stem cells expansion which are transplanted in patients with blood cancer. Cell expansion also has a potential to be used in various diseases linked with genetic defects such as Parkinson’s diseases or Alzheimer’s disease. Th...
- Platelet Rich Plasma Market (By Type: Pure PRP, Leucocytes and PRP, Platelet Rich Fibrin; By Origin: Autologous PRP, Allogeneic PRP, and Homologous PRP; By Application: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Other Surgeries) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
This report provides a comprehensive analysis of the platelet rich plasma market in Asia Pacific considering various macro as well as microeconomic factors such as regulations, applications of platelet rich plasma, and advantages and disadvantages of type of platelet rich plasma, and cost. The report studies the platelet rich plasma market from four perspectives: type of platelet rich plasma, origin of platelet rich plasma, application of platelet rich plasma, and country wise market. <...